首页> 美国卫生研究院文献>Aging (Albany NY) >Identification of the novel Np17 oncogene in human leukemia
【2h】

Identification of the novel Np17 oncogene in human leukemia

机译:在人白血病中新型NP17癌基因的鉴定

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We previously defined the HERV-K Np9 as a viral oncogene. Here we report the discovery of a novel oncogene, Np17, which is homologous to the viral Np9 gene and predominantly present in Hominoidea. Np17 is located on chromosome 8, consists of 7 exons, and encodes a 16.8kDa nuclear protein with149 amino-acid residue. Functionally, knockdown of Np17 induced growth inhibition of leukemia cells, whereas enforced expression of Np17 promoted growth of leukemia cells in vitro and in vivo. In human leukemia, Np17 was detected in 59.65% (34/57) of acute myeloid leukemia (AML) patients examined and associated with refractory/relapsed AML. Mechanistically, Np17 decreased p53 levels and its mechanism might be involved in recruiting nuclear MDM2 to p53 for ubiquitin-mediated degradation. These findings reveal that Np17 is a novel oncogene associated with refractory/relapsed leukemia.
机译:我们以前将Herv-K NP9定义为病毒癌基因。在这里,我们举报了对病毒NP9基因的新型癌基因NP17的发现,其主要存在于Hominoidea中。 NP17位于8染色体上,由7个外显子组成,并用149个氨基酸残基进行16.8KDA核蛋白。在功能上,NP17的敲低诱导白血病细胞生长抑制,而在体外和体内强制表达NP17促进白血病细胞的生长。在人白血病中,在59.65%(34/57)的急性髓性白血病(AML)患者中检测到NP17,与难治性/复发的AML相关。机械地,NP17降低了P53水平,其机制可能参与招募核MDM2至P53以进行泛素介导的降解。这些发现表明,NP17是与难治性/复发白血病相关的新型癌基因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号